Viekira Pak — Medica
Recurrent Hepatitis C Virus (HCV) Post-Liver Transplantation, Genotype 1
Initial criteria
- age ≥ 18 years
- The medication is prescribed in combination with ribavirin
- The medication is prescribed by or in consultation with a gastroenterologist, hepatologist, infectious diseases physician, or a liver transplant physician affiliated with a transplant center
Reauthorization criteria
- Patient has been started on Viekira Pak and needs remaining duration to complete course of therapy
Approval duration
24 weeks